Fully Funded Growth Strategy Fly Flyte, Inc. (“Flyte”), a newly acquired subsidiary of VTAK, is now positioned to execute its expansion strategy with a fully funded growth plan supported by its parent ...

FORT MILL, SC / ACCESSWIRE / February 22, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US-based medical device company focused on novel electrophysiology products, announced ...

VTAK has Agreed to Terminate its At-The-Market (“ATM”) Equity Offering Program Company Strengthens Balance Sheet and Aligns Institutional Capital for Long-Term Value Creation FORT MILL, S.C., Feb. 12, ...

POCI is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of POCI shares has increased $0.01 since the market last closed. This is a 0.23% ...

This data was produced from a multi-center study that enrolled 125 patients. The data demonstrates that VIVO was over 94% accurate, assisted physicians in determining workflow when used pre-procedure, ...

Catheter Precision announced its audit opinion raised concerns about ongoing financial stability, as detailed in its recent 10-K report. Catheter Precision, Inc. has announced that its 2024 annual ...

Catheter Precision (VTAK) stock jumped 60% after revealing an $11.55M deal to purchase Fly Flyte and Ponderosa, expanding into aviation infrastructure.